Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study
- PMID: 32015459
- DOI: 10.1038/s41397-020-0150-9
Association of HSPA1B genotypes with psychopathology and neurocognition in patients with the first episode of psychosis: a longitudinal 18-month follow-up study
Abstract
Our aim was to analyze the association of HSPA1B genotypes and treatment response measured by the changes of psychopathology and neurocognitive symptoms in patients with first-episode psychosis (FEP) after 18 months of treatment. A sample of 159 patients with FEP admitted at two Croatian psychiatric hospitals in the period between year 2014 and year 2017 was assessed at baseline and after 18 months of follow-up with Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS) and a battery of neurocognitive tests. Associations of scale and test results with HSPA1B polymorphic locus rs1061581 were analyzed using the general linear model. The carriers of the AA genotype showed the highest improvement in CDSS and RAVLT A test after the 18-month follow-up. Concordantly, we found significantly higher improvement assessed with the CDSS, RAVLT A, RAVLT A 30' and positive PANSS scales in the not-GG (AA/AG) group compared with the GG group. Our study suggests that HSPA1B rs1061581variants may moderate treatment response in FEP measured with changes of psychopathology and neurocognitive test results.
Similar articles
-
Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis.Eur Psychiatry. 2019 Sep;61:88-96. doi: 10.1016/j.eurpsy.2019.07.004. Epub 2019 Aug 6. Eur Psychiatry. 2019. PMID: 31398679
-
Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.Schizophr Res. 2014 Sep;158(1-3):113-9. doi: 10.1016/j.schres.2014.06.023. Epub 2014 Jul 5. Schizophr Res. 2014. PMID: 25008791
-
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Pharmacogenomics J. 2016 Oct;16(5):439-45. doi: 10.1038/tpj.2016.44. Epub 2016 Jun 7. Pharmacogenomics J. 2016. PMID: 27272046
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.Eur Neuropsychopharmacol. 2017 Jul;27(7):647-656. doi: 10.1016/j.euroneuro.2017.03.012. Epub 2017 Apr 5. Eur Neuropsychopharmacol. 2017. PMID: 28389049
-
Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.JAMA Psychiatry. 2019 Jan 1;76(1):61-70. doi: 10.1001/jamapsychiatry.2018.2552. JAMA Psychiatry. 2019. PMID: 30304442 Free PMC article. Clinical Trial.
Cited by
-
Nicotine Exposure in a Phencyclidine-Induced Mice Model of Schizophrenia: Sex-Selective Medial Prefrontal Cortex Protein Markers of the Combined Insults in Adolescent Mice.Int J Mol Sci. 2023 Sep 27;24(19):14634. doi: 10.3390/ijms241914634. Int J Mol Sci. 2023. PMID: 37834084 Free PMC article.
-
Network Integration Analysis and Immune Infiltration Analysis Reveal Potential Biomarkers for Primary Open-Angle Glaucoma.Front Cell Dev Biol. 2021 Dec 3;9:793638. doi: 10.3389/fcell.2021.793638. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34926471 Free PMC article.
References
-
- McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–76. http://www.ncbi.nlm.nih.gov/pubmed/18480098 . - PubMed - DOI
-
- Milner CM, Campbell RD. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics. 1990;32:242–51. http://www.ncbi.nlm.nih.gov/pubmed/1700760 . - PubMed - DOI
-
- International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–52. http://www.ncbi.nlm.nih.gov/pubmed/19571811 . - PMC - DOI
-
- Bergen SE, O’Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17:880–6. http://www.ncbi.nlm.nih.gov/pubmed/22688191 . - PubMed - PMC - DOI
-
- de Jong S, van Eijk KR, Zeegers DWLH, Strengman E, Janson E, Veldink JH, et al. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. Eur J Hum Genet. 2012;20:1004–8. http://www.ncbi.nlm.nih.gov/pubmed/22433715 . - PubMed - PMC - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical